Efficacy of cyclophosphamide combined with methylprednisolone impact therapy in the treatment of patients with moderate or severe Graves's ophthalmopathy

HAO Hairong; HU Wen; CHENG Liang; ZHANG Yong; XU Xiaowen; YU Weinan

doi:10.7619/jcmp.201611013

HAO Hairong, HU Wen, CHENG Liang, ZHANG Yong, XU Xiaowen, YU Weinan. Efficacy of cyclophosphamide combined with methylprednisolone impact therapy in the treatment of patients with moderate or severe Graves's ophthalmopathy[J]. Journal of Clinical Medicine in Practice, 2016, (11): 42-46. DOI: 10.7619/jcmp.201611013

Citation:

HAO Hairong, HU Wen, CHENG Liang, ZHANG Yong, XU Xiaowen, YU Weinan. Efficacy of cyclophosphamide combined with methylprednisolone impact therapy in the treatment of patients with moderate or severe Graves's ophthalmopathy[J]. Journal of Clinical Medicine in Practice, 2016, (11): 42-46. DOI: 10.7619/jcmp.201611013

Citation:

HAO Hairong, HU Wen, CHENG Liang, ZHANG Yong, XU Xiaowen, YU Weinan. Efficacy of cyclophosphamide combined with methylprednisolone impact therapy in the treatment of patients with moderate or severe Graves's ophthalmopathy[J]. Journal of Clinical Medicine in Practice, 2016, (11): 42-46. DOI: 10.7619/jcmp.201611013

Efficacy of cyclophosphamide combined with methylprednisolone impact therapy in the treatment of patients with moderate or severe Graves's ophthalmopathy

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Efficacy of cyclophosphamide combined with methylprednisolone impact therapy in the treatment of patients with moderate or severe Graves's ophthalmopathy

Catalog

Export File

Citation

Format

Content